Skip to content

Clinical trials

Phase 2 Arthritis, Rheumatoid trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Phase 2 Country / region: Germany Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20031
20056
20063
20075
20085
20097
20105
20118
20129
20135
20143
20155
20167
20192
20201
20212
20234
20258

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Terminated16
Recruiting5
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer9
GlaxoSmithKline6
Hoffmann-La Roche6
AstraZeneca5
Eli Lilly and Company5
Bristol-Myers Squibb4
AbbVie3
AbbVie (prior sponsor, Abbott)3
Ablynx, a Sanofi company3
Janssen Research & Development, LLC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid89
Arthritis4
Inflammation4
Autoimmune Diseases3
Lupus Erythematosus, Systemic3
Arthritis, Juvenile1
Immune System Diseases1
Joint Diseases1
Myasthenia Gravis1
Myositis1

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.